Neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Lille experience 1980–1996
- 28 February 1999
- journal article
- research article
- Published by Elsevier in Archives de Pédiatrie
- Vol. 6 (2) , 151-158
- https://doi.org/10.1016/s0929-693x(99)80202-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levelsThe Journal of Pediatrics, 1997
- Steroid 21-hydroxylase deficiency: genotype may not predict phenotypeJournal of Clinical Endocrinology & Metabolism, 1995
- Newborn screening for congenital adrenal hyperplasia in New ZealandThe Journal of Pediatrics, 1995
- Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorderScreening, 1993
- Genetic basis of endocrine disease 2: congenital adrenal hyperplasia due to 21-hydroxylase deficiencyJournal of Clinical Endocrinology & Metabolism, 1992
- Newborn screening, prenatal diagnosis, and prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiencyTrends in Endocrinology & Metabolism, 1990
- Should we screen for congenital adrenal hyperplasia? A review of 117 cases.Archives of Disease in Childhood, 1987
- Congenital adrenal hyperplasiaClinics in Endocrinology and Metabolism, 1985
- Neonatal screening for congenital adrenal hyperplasia.Archives of Disease in Childhood, 1983
- Plasma 17-hydroxyprogesterone concentrations in ill newborn infants.Archives of Disease in Childhood, 1983